Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeremy Murray

Showing results (41-50 of 65) with videos related to

Pageof 7
Sort By:
Journal of Medicinal Chemistry|November 21, 2017
A Unique Approach to Design Potent and Selective Cyclic Adenosine Monophosphate Response Element Binding Protein, Binding Protein (CBP) InhibitorsSarah M Bronner, Jeremy Murray, F Anthony Romero, et al.
Science (New York, N.Y.)|July 4, 2024
Genomic investigation of 18,421 lines reveals the genetic architecture of riceXin Wei, Mengjiao Chen, Qi Zhang, et al.
Journal of Medicinal Chemistry|October 11, 2011
Discovery of a potent, selective, and orally available class I phosphatidylinositol 3-kinase (PI3K)/mammalian target of rapamycin (mTOR) kinase inhibitor (GDC-0980) for the treatment of cancerDaniel P Sutherlin, Linda Bao, Megan Berry, et al.
ACS Medicinal Chemistry Letters|September 22, 2023
Discovery of Selective Tertiary Amide Inhibitors of Cyclin-Dependent Kinase 2 (CDK2)Mingshuo Zeng, Jessica M Grandner, Marian C Bryan, et al.
Journal of Bacteriology|April 20, 2021
Inhibition of Escherichia coli Lipoprotein Diacylglyceryl Transferase Is Insensitive to Resistance Caused by Deletion of Braun's LipoproteinJingyu Diao, Rie Komura, Tatsuya Sano, et al.
European Journal of Medicinal Chemistry|July 23, 2013
Lead identification of novel and selective TYK2 inhibitorsJun Liang, Vickie Tsui, Anne Van Abbema, et al.
Journal of Medicinal Chemistry|May 18, 2012
Identification of imidazo-pyrrolopyridines as novel and potent JAK1 inhibitorsJanusz J Kulagowski, Wade Blair, Richard J Bull, et al.
Bioorganic & Medicinal Chemistry Letters|April 2, 2013
Discovery of thiazolobenzoxepin PI3-kinase inhibitors that spare the PI3-kinase β isoformSteven T Staben, Chudi Ndubaku, Nicole Blaquiere, et al.
Journal of Medicinal Chemistry|October 24, 2022
Overcoming Preclinical Safety Obstacles to Discover (<i>S</i>)-<i>N</i>-((1,2,3,5,6,7-Hexahydro-<i>s</i>-indacen-4-yl)carbamoyl)-6-(methylamino)-6,7-dihydro-5<i>H</i>-pyrazolo[5,1-<i>b</i>][1,3]oxazine-3-sulfonamide (GDC-2394): A Potent and Selective NLRP3 InhibitorChristopher McBride, Lynnie Trzoss, Davide Povero, et al.
Journal of Medicinal Chemistry|October 6, 2018
GNE-371, a Potent and Selective Chemical Probe for the Second Bromodomains of Human Transcription-Initiation-Factor TFIID Subunit 1 and Transcription-Initiation-Factor TFIID Subunit 1-likeShumei Wang, Vickie Tsui, Terry D Crawford, et al.
Pageof 7

Showing results (41-50 of 65) with videos related to

Sort By:
Pageof 7
Journal of Medicinal Chemistry|November 21, 2017
A Unique Approach to Design Potent and Selective Cyclic Adenosine Monophosphate Response Element Binding Protein, Binding Protein (CBP) InhibitorsSarah M Bronner, Jeremy Murray, F Anthony Romero, et al.
Science (New York, N.Y.)|July 4, 2024
Genomic investigation of 18,421 lines reveals the genetic architecture of riceXin Wei, Mengjiao Chen, Qi Zhang, et al.
Journal of Medicinal Chemistry|October 11, 2011
Discovery of a potent, selective, and orally available class I phosphatidylinositol 3-kinase (PI3K)/mammalian target of rapamycin (mTOR) kinase inhibitor (GDC-0980) for the treatment of cancerDaniel P Sutherlin, Linda Bao, Megan Berry, et al.
ACS Medicinal Chemistry Letters|September 22, 2023
Discovery of Selective Tertiary Amide Inhibitors of Cyclin-Dependent Kinase 2 (CDK2)Mingshuo Zeng, Jessica M Grandner, Marian C Bryan, et al.
Journal of Bacteriology|April 20, 2021
Inhibition of Escherichia coli Lipoprotein Diacylglyceryl Transferase Is Insensitive to Resistance Caused by Deletion of Braun's LipoproteinJingyu Diao, Rie Komura, Tatsuya Sano, et al.
European Journal of Medicinal Chemistry|July 23, 2013
Lead identification of novel and selective TYK2 inhibitorsJun Liang, Vickie Tsui, Anne Van Abbema, et al.
Journal of Medicinal Chemistry|May 18, 2012
Identification of imidazo-pyrrolopyridines as novel and potent JAK1 inhibitorsJanusz J Kulagowski, Wade Blair, Richard J Bull, et al.
Bioorganic & Medicinal Chemistry Letters|April 2, 2013
Discovery of thiazolobenzoxepin PI3-kinase inhibitors that spare the PI3-kinase β isoformSteven T Staben, Chudi Ndubaku, Nicole Blaquiere, et al.
Journal of Medicinal Chemistry|October 24, 2022
Overcoming Preclinical Safety Obstacles to Discover (<i>S</i>)-<i>N</i>-((1,2,3,5,6,7-Hexahydro-<i>s</i>-indacen-4-yl)carbamoyl)-6-(methylamino)-6,7-dihydro-5<i>H</i>-pyrazolo[5,1-<i>b</i>][1,3]oxazine-3-sulfonamide (GDC-2394): A Potent and Selective NLRP3 InhibitorChristopher McBride, Lynnie Trzoss, Davide Povero, et al.
Journal of Medicinal Chemistry|October 6, 2018
GNE-371, a Potent and Selective Chemical Probe for the Second Bromodomains of Human Transcription-Initiation-Factor TFIID Subunit 1 and Transcription-Initiation-Factor TFIID Subunit 1-likeShumei Wang, Vickie Tsui, Terry D Crawford, et al.
Pageof 7